title: Transurethral ethanol ablation of prostate.
abstract: Transurethral ethanol ablation of the prostate (TEAP) has emerged among the treatment alternatives to transurethral resection of prostate as a promising minimally invasive therapy that can be performed on an outpatient basis with fewer complications. It was introduced approximately 5 years ago, and to date, 12-month results are encouraging. We herein review the procedure and outcomes of TEAP.
authors.affiliation: Department of Urology, Barts and The Royal London Hospitals, London, United Kingdom.
authors.forename: Noor N P
authors.initials: NN
authors.lastname: Buchholz
authors.forename: Henry O
authors.initials: HO
authors.lastname: Andrews
authors.forename: Mark K
authors.initials: MK
authors.lastname: Plante
mesh_terms: D000431:Ethanol / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*; D014521:Urethra
chemical_list: D000431:Ethanol